What is Behavioral Pharma?
Behavioral Pharma, headquartered in San Diego, California, operates as a Contract Research Organization (CRO) dedicated to providing customized in vivo pre-clinical testing services. The company's core expertise lies in behavioral neuroscience research, offering a collaborative framework that encompasses experimental design, real-time data analysis, and the application of validated behavioral testing methodologies. Since its inception in 2001, Behavioral Pharma has established a strong reputation for delivering reliable and reproducible data, thereby supporting complex neuroscience experiments for a diverse clientele, including academic institutions and pharmaceutical companies.
How much funding has Behavioral Pharma raised?
Behavioral Pharma has raised a total of $41K across 1 funding round:
Debt
$41K
Debt (2021): $41K with participation from PPP
What's next for Behavioral Pharma?
With the recent influx of significant expansion capital, Behavioral Pharma is strategically positioned for accelerated growth. The substantial Series B/C stage funding indicates a maturation phase, likely enabling the company to scale its operations, enhance its service offerings, and potentially expand its research capabilities. This investment will be critical in solidifying its market position as a leading provider of specialized pre-clinical testing services in the competitive neuroscience research landscape. Future developments may include technological advancements in data acquisition and analysis, as well as broader strategic partnerships within the pharmaceutical industry.
See full Behavioral Pharma company page
